跳至主要内容
临床试验/IRCT2014112320051N2
IRCT2014112320051N2已完成3 期

Comparison of the efficacy and safety of herbal product (Resveratrol) with Hydroxyurea (HU) in non- transfusion- dependent B-thalassemia-intermedia

Vice Chancellor for Research, Shiraz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • non transfused in the 6 months ago; patients who did not receive HbF- inducer in the 6 months ago; normal liver or kidney function tests; normal CBC test.
  • Exclusion criteria: Patients will be excluded from this trial if they have one of the following criteria: Abnormal liver or kidney function tests; An alanine aminotranferase (ALT) level and aspartate aminotransferase (AST) greater than 3 fold; serum creatinine level above the upper limit of normal; they can leave the study when they want

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research, Shiraz University of Medical Sciences

相似试验